N atural products, the secondary or nonprimary metabolites produced by living organisms, have been exploited by people for a variety of purposes including use as food, fragrances, pigments, insecticides, and medicines. Historically, plants have served as the major source of medicinally useful natural products, developed from a legacy of folk medicine based on herbal remedies. Today, some 25% of all pharmaceutical sales are drugs derived from plant natural products, and an additional 12 % are based on microbially produced natural products (Joffe and Thomas J 989) . Despite these successes and the belief that the microbial, plant, and invertebrate diversity in the marine environment may exceed that of terrestrial habits, research into the use of marine natural products as pharmacological agents is only now becoming a mature discipline. The marine environment lacks an ethnomedical history, and it is difficult to collect marine organisms (Faulkner 1992) .
Modern marine natural products research began approximately 40 years ago with the study of organisms from intertidal and shallow subtidal environments, where samples are easily accessible by wading and snorkeling. In the 1960s the use of SCUBA Brad K. Carte is a senior investigator, Biomolecular Discovery, at SmithKline Beecham Pharmaceuticals, 709 Swedeland Rd., King of Prussia, PA 19406. © 1996 American Institute of Biological Sciences.
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Brad K. Carte The manne environment is a rich source of biologically active natural products, many of which have not been found in terrestrial sources diving as a scientific tool enabled researchers to begin looking at shallow water subtidal organisms to a depth of approximately 40 m. Over the last decade, advances in diving technology have opened up vast areas of unexplored marine environments and habitats to marine natural product scientists. Depths of up to 200 m are now accessible using computerized closed-circuit mixedgas rebreathers, and depths of 1000 m and beyond are becoming accessible with the use of remotely operated vehicles and manned submersibles.
The marine environment is an exceptional reservoir of bioactive natural products, many of which exhibit structural features not found in terrestrial natural products (Ireland et al. 1988) . Each year, an increasing number of novel marIne metabolites are reported in the literature, indicating that the marine environment is likely to continue to be a prolific source of new natural products for many years to come. Approximately 2500 new metabolites were reported from a variety of marine organisms during the decade from 1977 -1987 ). In 1992, more than 200 papers were published describing the structures and initial bioactivity profiles of more than 500 new natural products from matine organisms (Carte 1993) . Many additional papers appear each year that describe the synthesis or the biochemical and pharmacological characterization of marine natural products.
In the 1960s, research on marine natural products was driven by chemical studies; few compounds were tested for any relevant bioactivity. The biomedical potential of marine natural products became apparent in the second decade of research, beginning with the inauguration of a series of symposia on food and drugs from the sea sponsored by the Marine Technology Society (Youngken 1970) . The 1980s saw an increasing collaborative effort between marine chemists and pharmacologists, which led to the discovery of the first marine metabolites to enter preclinical studies and clinical trials. In addition, many marine compounds have been found to be useful as biochemical tools for exploring cellular processes at the molecular level.
Throughout the 1980s, biomedical investigations of marine natural products focused on central nervous system membrane-active toxins and ion channel effectors, anticancer and antiviral agents, tumor promoters, and anti-inflammatory agents (Ireland er al. 1993 ). The 19905 have begun with an even more sophisticated collaboration between natural product chemists, molecular pharmacologists, biochemists, and eel! biologists. At the same time, advances in molecular and biochemical pharmacology, recombinant DNA technologies, and genomic analyses are resulting in the identification of an ever-increasing number of possible molecular targets to use in drug discovery programs. These developments have led to a renewed interest in screening technologies by the pharmaceutical and biotechnology industries and to a concerted effort to screen chemical libraries, both of natural product collections and of synthetic compounds produced by combinatorial methods (Gordon et a!. 1994) , in a variety of specific enzyme inhibition and receptor antagonist bioassays. These developments ensure that the current decade is likely to be the most exciting yet for the field of marine natural products chemistry. This article reviews some highlights from the field and concentrates on those natural products that have undergone more than preliminary biological evaluation to provide compounds with potential use as therapeutics, as lead structures for the development of potential therapeutics, or as molecular probes being used for the study and understanding of complex cellular and biochemical processes at the molecular level. To highlight the exceptional chemical diversity provided by sources in the marine environment, this article is organized phylogenetically because biological diversity often equates with chemical diversity.
For more detailed information, I refer the reader to the many previ-OllS reviews of the field. These include general reviews on the biomedical potential of marine natural products (Carte 1993 , Jacobs et al. 1993 , as well as more specific reviews on marine natural products with antiparasitic activity (Crews and Hunter 1993) , antiviral activity (Rinehart et al. 1993 ), cytotoxic and antirumor activity (Schmitz et al. 1993) , and on marine toxins (Yasumoto and Murata 1993) . A comprehensive review that concentrates on reports of novel marine natural products with interesting biological and pharmaceutical properties is published yearly (e.g., faulkner 1995).
Marine bacteria
Microorganisms have had a major impact on the development of medical science since the discoverv that they not only are the cause o(infection but also produce organic compounds that can both cure infections and help treat a variety of noninfectious diseases. Traditionally, microbial products discovery has focused on antimicrobial and antitumor activity of soil bacteria and fungi, and, since the original discovery of penicillin in 1929, nearly 50,000 natural products have been discovered from microorganisms (Betina 1983) . Of these, more than 10,000 are reported to have biological activity and more than 100 microbial products are in use today as antibiotics, antitumor agents, and agrochemicals. With the recent advances in molecular biology and mechanism-based drug discovery, the microbial world is likely to continue to provide new natural products with a range of pharmacological activities, as is evident from the development of the fungal me-taboriee mevinolin for the treatment of high serum cholesterol and the bacterial metabolite FK-S06 as an immunosuppressant agent.
Despite the success in drug discovery using terrestrial microorganisms, the marine microbial world has until recently been largely ignored as a source of new biologically active natural products. Early indications that marine microorganisms represent a potential source of biomedically useful compounds came from studies showing that marine bacteria produce antimicrobial agents (Rosenfeld and Zobell 1947) . Early work that followed resulted in the identification of metabolites previously known from terrestrial bacteria and the perception that marine bacteria were extremely difficult to isolate and culture, although the conditions used were the same as those that had been developed over many years for terrestrial bacteria.
It was the pioneering work of Bill Fenical and his colleagues at the Scripps Institution of Oceanography that showed that marine bacteria are uniquely adapted to saline environments. Fenical undertook the basic research to develop selective marine isolation and mass culture media that use natural nutrients and growth factors derived from marine sources. Results from these studies are encouraging, and marine bacteria are now known to be capable of producing unusual bioactive natural products that are not observed from terrestrial sources (Fenical 1993, Fenical and Jensen 1993) .
An example was the isolation by the Fenical group of a novel class of antiviral and cytotoxic macrolides from a deep-sea marine bacterium (Gustafson et a1. 1989 ). This unusual Gram-positive bacterium, which could not be identified by normal taxonomic methods, was isolated from a deep-sea sediment core and grown in liquid culture. It produced a series of new natural products, macrolactins A-F, of an unprecedented C24 linear acetogenin origin. The major metabolite, macrolactin A (Figure 1a ), inhibits B16-F10 murine melanoma cancer cells in in vitro assays, shows significant inhibition of mammalian Herpes simplex viruses (types I and II), and April 1996 protects T-Iymphoblast cells against human HIV viral replication.
The study of marine bacteria has also led to the realization that microorganisms that form specific symbiotic relationships with marine macroorganisms may be responsible for the production of some of the bioactive compounds that have been isolated from such organisms (Kobayashi and Ishibashi 1993) . The discovery that several well-known marine toxins are produced by marine microorganisms is a striking example. The potent neurotoxin tetrodotoxin (figure 1 b) has been known for years and was considered to be produced by pufferfish of the family Tetraodontidae. In Japan, pufferfish are considered a delicacy, and great care is taken in preparing and consuming the flesh of these toxic fish. Recent studies have shown conclusively that tetrodotoxin is produced by many unicellular marine bacteria (Simidu et a1. 1990) .
Similarly, saxitoxin ( Figure 1c ) and related toxins, the well-known causes of paralytic shellfish poisoning, are present in several dinoflagellates, including Alexandrium spp., Gymnodinium catena tum, and Pyrodinium hahamense, which are concentrated by filter-feeding shellfish. These dinoflagelletes may acquire saxitoxin from bacteria rather than synthesizing it themselves; however, this claim has been made on poor evidence and needs confirmation by more sophisticated methods (Yasumoto and Murata 1993) .
Both tetrodotoxin and saxitoxin are potent and specific sodium channel blockers that have served as important tool compounds for the study of ion channels. Indeed, pharmacological studies with tetrodotoxin and saxitoxin played a major role in developing the concept of sodium channels in particular and membrane channels in general (Kao and Levinson 1986). These toxins have been useful in neurophysiology and neuropharmacological studies and are expected to continue to be important tools for the study of sodium channels.
Marine microalgae
The second major group of marine microorganisms whose natural prod-lIct chemistry has been studied are the microalgae, or phytoplankton (Shimizu 1993a) . Despite their small size, phytoplankton afe fundamental to the marine food chain because they are major primary producers, converting carbon dioxide into organic compounds that can be subsequently used by invertebrates and fish. There are more than 10,000 species of microalgae, which are found in five major divisions. The majority of the natural product investigations have concentrated on two of these divisions-the bluegreen algae and the dinoflagellates.
Blue-green algae, or cyanobacteria (Cyanophyta), arc found almost everywhere that light and water are available. Depending on the choice of systematics, the Cyanophyta can be classified as either microalgae or bacteria. Strictly speaking, the Cyanophyta are prokaryotic, yet they resemble algae in that they are photosynthetic and are a conspicuous component of the phytoplankton. They are individually microscopic but may aggregate to form macroscopic colonies. In freshwater environments, blooms of toxic Cyanophytes can cause severe dangers for wildlife and livestock.
Several interesting bioactive metabolites have been isolated from Cyanophytes (Moore et a1. 1988 ). Most natura! product investigations of Cyanophytes have concentrated on freshwater species, which appear to be much easier to cultivate than marine species. However, some of the most important Cyanophyte natural products have been isolated from the marine filamentous bluegreen alga Lyngbya majuscula. Two highly inflammatory but structurally different metabolites, lyngbyatoxin A (Figure 1d ) and debromoaplysiatoxin ( Figure Ie) , were isolated from toxic strains of L. majuscula collected in Hawaii and shown to be the cause of the severe contact dermatitis known as swimmer's itch (Cardellina et a1. 1979 ). Both classes of compound have played a significant role in the study of protein kinase C (PKC), an enzyme that is an important regulatory component of many signal transduction pathways. Phorbol esters are a class of plant natural products that, via activation of PKC, promote tumors in animals exposed to carcinogens. The discovery that both lyngbyatoxins and aplysiatoxins bind to the phorbol ester receptor on PKC (Fujiki and Sugimura 1987) provided important insights into the strucrure of this receptor. This knowledge may lead to the design of analogs useful as both tumor-suppressing compounds and as probes for PKC's mechanism of action (Wender et al. 1986 ).
Two additional classes of potentially important marine natural products were isolated from Caribbean collections of L. majuscula. A Venezuelan collection yielded two immunosuppressive linear pep-. tides-microcolins A and B. The major metabolite, microcolin A (Figure 1 f ), suppressed the two-way murine mixed lymphocyte reaction at low nanomolar concentrations (Koehn et al. 1992) . Using toxicity to brine shrimp as a bioassay, a new lipid with a unique thiazoline-containing structure, curacin A ( Figure  19 ; Gerwick et a1. 1994) , was purified from the organic extract of a Cura~ao collection of L. majuscula.
Curacin A is an exceptionally potent anti proliferative agent that shows some selectivity for colon, renal, and breast cancer-derived cell lines. Mechanistic evaluation demonstrated that curacin A inhibits the polymerization of purified tubulin, a mechanism of action shared by several clinically useful anticancer drugs. Although all clinically useful rubulin polymerization-inhibiting anticancer drugs are known to bind to the same site at which the drug vinblastine binds, curacin A binds to a different region on the tubulin monomer, the colchicine binding site. Thus, the discovery of curacin A opens the door for the potential development of a new class of anticancer drugs that inhibit tllbulin polymerization by binding at the colchicine site.
Dinoflagellates (Pyrrophyta) are unicellular eukaryotic microalgae found in both marine and freshwater environments. Certain characteristics of the division Pyrrophyta have convinced many taxonomists to include these organisms as part of the animal kingdom. Some species are not photosynthetic but obtain energy by ingesting particulates.
Most are motile, using a pair of flagella. Despite these nonplant features, most marine dinoflagellates are photosynthetic, and their share of the total marine primary plant production is significant. Under optimal growth conditions, dense blooms of toxic (so-called red tide) or luminescent dinoflagellates can occur. The chemistry of the dinoflagellates is dominated by the study of shellfish toxins and polyether antibiotics of unusual structural classes (Shimizu 1993b) .
Brevetoxins are the toxic components of the Gulf of Mexico red tide organism, Ptychodiscus brevis (formerly Gymnodinium breve), which can inflict extensive damage to the marine ecosystem. The most toxic compound, brevetoxin A, has a novel polyether structure (Shimizu et al. 1986 ). Brevetoxins are selective sodium channel activators that depolarize excitable membranes. Their binding site on sodium channels seems to be different from that of other activators, and brevetoxins have quickly become important in biomedical research, in which they are widely used as molecular probes. Cultures of the marine dinoflagellate Gambierdiscus toxicus isolated from French Polynesia have yielded a series of novel polyether antibiotics that are the most potent in vitro antifungal agents reported to date. The most potent of these, gambieric acid A, is 2000-fold more active rhan the clinically useful antifungal agent amphotericin-B and shows only moderate toxicity against mice and cultured mammalian cells (Nagai et al. 1992) .
Probably one of the most important classes of enzyme inhibitors from marine organisms is the okadaic acid ( Figure Ih ) class of selective protein phosphatase inhibitors. Okadaic acid, a polyether fatty acid that was first isolated from the marine sponge Halichondria okadai, was later shown to be produced by marine dinoflagellates of the genus Prorocentrum and is concentrated in marine sponges by filter feeding. Little was known about protein phosphatases, which, along with kinases, determine the phosphorylation levels of target proteins, until the discovery of okadaic acid. In the past few years, this molecule has become an extremely powerful probe for studying regulatory phenomena and signal transduction pathways in eukaryotic cells (Cohen et al. 1990 ). In more than 20 papers published in 1992 alone, okadaic acid was used to study regulatory ph os p h ory I a ti 0 n -de p h 0 s phory-!ation events (Carte 1993) .
Seaweeds
The majority of the large conspicuous forms of attached marine plants are the seaweeds, predominately those in the three plant divisions Chlorophyta (green algae), Phaeophyta (brown algae), and Rhodophyta (red algae). Each group is characterized by specific combinations of photosynthetic pigments. The seaweeds are extremely abundant in intertidal zones, and in clear tropical waters they can extend to depths of up to 200 m. Where abundant, the seaweeds greatly influence environmental conditions for other types of marine life by providing food, protection from waves, shade, and a substrate on which to attach. Due to their abundance in shallow waters and ease of collection, the seaweeds were one of the first groups of marine organisms whose natural products chemistry was studied extensively. The percentage of work on seaweeds has declined over the last decade in favor of more studies with marine invertebrates. Because the majority of the work on seaweeds occurred before the development of many of the useful mechanistic bioassays used today, there are few reports of biological activity beyond the standard antimicrobial and in vitro cytotoxicity tests for seaweed metabolites.
The bright green color characteristic of the green algae (Chlorophyta) is due to the predominance of chlorophyll over other accessory photosynthetic pigments. Although chemical studies of temperate species have not been productive, the tropical green algae are known to produce many interesting biologically active metabolites. The chemical ecology of many of these, such as halimedatrial ( Figure 2a ; Paul and Fenical 1983), has he en studied extensively, but only cursory pharmacological studies have been done. A recent exception was the bioassayguided isolation of the novel sphingosine derivative N-palmitoyl-2amino-1,3,4,5-tetrahydroxyoctadecane ( Figure 2b ), which has antiviral activity in vivo, from the green algae Ulva {asciata collected off of the West coast of India (Garg et al. 1992 ).
In the brown algae (Phaeophyta), the green hue of chlorophyll is partially masked by the golden xanthophyll accessory photosynthetic pigments. Many of the large, more familiar and dominant algae of temperate seas, such as the kelp, belong to this division. Natural product studies of this division have been productive, with many reports of biologically active metabolites, predominately diterpenes. Stypoldione ( Figure 2c ) was isolated as an oxidation product of a potent fish toxin excreted by the tropical brown algae Stypopodium zona Ie collected in the Caribbean (Gerwick and Fenical 1981) . Stypoldione was found to be cytotoxic by inhibiting mitotic spindle formation via inhibition of microtubule polymerization, the mechanism of action for several clinically useful anticancer agents. The mechanism by which polymerization was blocked contrasts with that of the known microtubule inhibitors and suggests the possible use of stypoldione as a pharmacological probe for the study of cell cycles (Jacobs et al. 1985) .
The red algae (Rhodophyta) contain, in addition to chlorophyll, the accessory red phycoerythrin and blue phycocyanin pigments. They can display a wide range of colors, from bright green to various shades of red, and are as diverse in structure and habitat as they are in coloration. The chemistry of the red algae has been studied extensively because of their propensity to include halogens in their biosynthetic pathways. drug discovery screen that looks for selective activity in a human tumor cell line panel consisting of 60 different cell lines representing eight major cancer subtypes. Halomon produced one of the most extreme examples of differential cytotoxicity to date in this NCI screen. Brain, renal, and colon tumor cell lines were most sensitive to this compound, which has been selected by the NCI Decision Network Committee for preclinical drug development.
Although further development of halomon has been constrained by the small amounts of natural material available to date and the lack of synthetic methods to produce the compound, preliminary in vivo evaluations of halomon have been encouraging (Fuller et a1. 1994) . Additional biologically active metabolites have also been isolated from the red algae. An Australian collection of Hypnea valetiae produced a novel iodinated nucleoside, 5' -deoxy-5 -iodotubercidin ( Figure  2e ), which is a potent and specific inhibitor of adenosine kinase. This nucleoside has been used to study adenosine receptors in a variety of systems and has found wide application in studies of nucleotide metabolism and regulation , and references therein).
One of the more exciting recent developments in the study of algal chemistry has been the discovery that many algae convert simple polyunsaturated fatty acids, such as arachidonic acid, into complex eicosanoids and related oxylipins (2e) 5'-Deoxy-S.lodoluberddln (Gerwick and Bernart 1993) _ .Most work has been on the red algae, but there have been reports for both green and brown algae as well. In mammalian systems, these arachidonic acid derivatives are important for maintaining normal physiological conditions, a process known as homeostasis. The aberrant production of metabolites of this structural class underlies several diseases, including inflammation, pSOriaSIS, asthma, atherosclerosis, heart disease, ulcers, and cancer. Given the potent biological activity of these compounds, it is likely that the marine eicosanoid analogs will possess potent pharmacological properties, stimulating their development as new pharmacological tools and perhaps pharmaceutical agents to treat these diseases (Gerwick 1993) .
Although normally considered primary metabolites and not natural products, marine algal polysaccharides have medicinal and biotechnological applications that are worth mentioning (see also Radmer this issue)_ Carrageenans and agar, from which agarose is derived, are harvested commercia\1y from a variety of red algae, and algi nates are obtained commercial!y from several species of brown algae. There are reports of algal sulfated polysaccharides exhibiting a variety of activities including antiviral, antithrombic, antitumor, antiulcer, antilipemic, and immunomodulating. Their inflammatory and immunomodulating activities have made them useful in several pharmacological assays used to discover potential therapeutics_ OM. "~I " 
Metabolites from marine sponges.
Many anti-inflammatory agents have been discovered using the carrageenan-induced non immune inflammatory response, rat paw edema assay. In addition, most of the major advances in modern biotechnology would not have been possible without the availability of agar and agarose polysaccharides from seaweeds. Their use in products from media for microbial growth to gels for the electrophoretic separations of proteins and DNA has enabled the development of modern biotechnological tools and techniques leading to new therapeutics (Renn 1993) .
Sponges
Sponges are the simplest of the multicellular animals. They differ from other groups of invertebrates in that they maintain an almosr protozoan independence for their constituent cells, which form no true tissue layers or organs. Depending on a cell's location within the sponge, it does however, perform specialized func-276 tions. The life of a sponge centers around pumping a high volume of water through its tissues, filtering out food and oxygen. The sponge body is organized around a system of pores, ostia, canals, and chambers, which conduct water current from the inhalant sponge surface to the exhalant apertures, the oscules. Sponges come in many colors, shapes, and sizes, from millimeterthin encrustations to branching ropes to giant barrel sponges more than six feet in height. Sponges appeared on Earth more than 500 million years ago and are widely found, from pole to pole and from intertidal zones to water thousands of meters deep.
Because of their prevalence, ease of collection, and ability to biosynthesize a variety of natural product structural classes, the sponges have become one of the dominant sources of biologically active marine natural products. The pioneering work of Bergmann on sponge nucleosides ",.,
(3") Diso:od.,nwli<k played a catalytic role in promoting the search for biologically active marine natural products. During the 1950s, Bergmann and coworkers isolated a series of arabinosyl nucleosides from the Caribbean sponge Cryptotethia crypta, of which the major was the potent tumor inhibitor spongouridine. This discovery provided the pharmacophore lead, which led to the synthesis of a new class of arabinosyl nucleoside analogs. One such analog, arabinosyl cytosine (ara-C), displayed potent in vivo antileukemic activity. Ara-C derives its activity by conversion to arabinosyl cytosine triphosphate, incorporation into cellular DNA, and subsequent inhibition of DNA polymerase.It is currently in clinical use for the treatment of acute myelocytic leukemia and non-Hodgkin's lymphoma , and references therein).
Following the discovery of spongouridine and subsequent development of the clinically useful ara-C, the search for cytotoxic compounds has been a major goal in marine natural products research. In the five-year period from 1986 to 1991, more than 400 novel marine natural products with cytotoxic activity were reported in the literature (Schmitz et al. 1993 ). Unfortunately, the majority of these have only been tested for preliminary cytotoxic activity in cell culture, and few have been further analyzed for more relevant in vivo antitumor activity. Several notable exceptions have been reported from ma rine sponges.
The deep-water sponge Dercitus sp. collected in the Bahamas yielded the novel aminoacridine alkaloid dercitin (Figure 3a) , which possesses in vitro cytotoxic activities in the low nanomolar concentration range. In animal studies, dercitin prolonged the life of mice bearing ascitic P388 tumors (TIC 170 [70% increase in life span I at 5 mg/kg) and was also active against 816 melanoma cells and small cell Lewis lung carcinoma. Mechanistic studies ) indicate that dercitin probably exerts its biological effects through DNA intercalation, the mechanism of action of several clinically useful anticancer agents. The data suggest that dercitin may be a promising "lead compound" for systematic modifications in search for solid tumor-specific cancer chemotherapeutic agents .
Japanese collections of the sponge H. okadai have yielded several biologically active polyether macrolides. One of these macrolides, halichondrin B (Figure 3b ), has shown potent activity in vivo against P388 leukemia cells (TIC 323 at 10 ).lg/kg) and B16 melanoma cells (TIC 244 at 5 ~g/kg; Hirata and Uemura 1986). Because a TIC above 300 is considered curative in these protocols, the halichondrins have generated much interest as potential anticancer agents.
Marine sponges of the genus Theonella are a rich source of bioactive natural products possessing novel structu ral features. A J a panese collection of Theonelia sp. ga ve a series of five novel multifunctional heterocyclic peptides, the theopederins A-E. The theopederins were markedly cytotoxic against P388 murine leukemia cells, with IC,o's April 1996 below 1 ng/mL; the most potent, theopederin A (figure 3c), exhibited promising antitumor activity against P388 in vivo (TIC 205 at 0.1 mg/kg; Fusetani et al. 1992 ). The theopederins are structurally related to mycalamide A from the marine sponge Mycale sp., collected in New Zealand (Perry et al. 1988) , and onnamide A from the marine sponge Theoneila sp., collected in Okinawa (Sakemi et al. 1988 ). Both compounds show potent in vitro cytotoxicity and in vivo antitumor activity in many leukemia and solid tumor model systems, providing additional evidence of the potential of this class of compounds as anticancer agents .
Other cytotoxic sponge metabolites deserve mention, despite the lack of available in vivo data, because of their potency and selectivity in the NCI's human tumor cell line panel. Deep-blue specimens of Cribrochalina sp. collected in the Indian Ocean produced a series of cytotoxic isoquinolinequinones. Cribrostatin 1 (Figure 3d) shows selective activity against all nine human melanoma cell lines in the NCI's panel (Pettit et al. 1992 ). Similar isoquinolinequinones have been isolated from deep-blue species of the sponge genera Reniera and Xestospongia. These include the known Streptomyces metabolite mimosamycin, suggesting a possible role of a symbiotic microorganism in the biosynthesis of this class of marine natural products, a recurring theme in the study of sponge natural products. Indian Ocean collections of a Spollgia sp. have yielded a series of macrocyclic lactones, the spongistatins, with remarkably potent activity in the NeI's 60-celiline panel. spongistatin 1 is the most potent substance known against a subset of highly chemoresistant tumor types in the Kel tumor panel (Pettit et al. 1993) . Cribostatin 1, mimosamycin, and spongistatin 1 are all undergoing further detailed antineoplastic evaluation.
Alternative strategies for the discovery of antitumor compounds use a more mechanism-based approach. Researchers at Smith Kline Beecham have developed a high-throughput screening assay using genetically engineered mutants of the yeast Saccharomyces cerevisiae to detect inhibitors of DNA to poi some rases, enzymes that catalyze the interconversion of various topological forms of DNA. Topoisomerases are the primary cellular targets of sevcrJl clinically important anticancer agents. Using this assay, a novel pentacyclic alkaloid, neoamphimedine (Figure 3e) , was isolated from a sample of the sponge Xestospongia carbona ria collected in Palau. Neoamphimedine is a potent inhibitor of purified DNA topoisomerase II, retains activity in cell lines resistant to other topoisomerase II inhibitors, and displays weak antitumor activity in vivo. I Researchers at Lederle Labs in New York and the University of Utah have isolated and characterized a series of novel cytotoxic pyrroloiminoquinones, the makaluvamines A-F, from Fijian sponges of the genus Zyzzya (Barrows et al. 1993 ). The makaluvamines exhibit potent in vitro cytotoxicity toward the human colon tumor cell line HCT 116, show differential toxicity toward a topoisomerase II-sensitive cell line, and inhibit purified DNA topoisomerase II. Makaluvamines A ( Figure 3f ) and C (Figure 3g ) exhibit in vivo antitumor activity against a human ovarian carcinoma.
The use of mechanism-based enzyme inhibition and receptor binding assays in the search for and characterization of biologically active metabolites from marine organisms is expanding, and many examples from marine sponges have been reported. The potent phosphatase inhibitor okadaic acid (Figure 1 h) was first isolated from a sponge, although it is produced by a dinoflagellate, as described earlier. Other potent and selective phosphatase inhibitors from sponges include the cyclic pentapeptide motuporin (Figure 3h ) from Theonella swinhoei collected off Papau New Guinea (De Silva et a !. 1992 ) and calyculin A (Figure 3i ) from Discodermia calyx (Kato et at. 1986 ). Calyculin A is a spiro ketal with a novel skeleton bearing phosphate, oxazole, nitrile, and amide groups. Calyculin A is rc-lB. K. Carte, 1992, unpublished (bra. ported to be a more potent inhibitor of protein phosphatases than okadaic acid (Ishihara et a1. 1989 ), although okadaic acid, which is commercially available, is more widely used in biochemical research.
Purealin (figure 3j), a bromotyrosine-derived alkaloid from the sponge Psammapiysilla purpurea, affects various myosin ATPases. Biochemical characteri:zation indicated that purealin inhibits myosin phosphorylation by acting as a calmodulin antagonist; this alkaloid has therefore become a tool to investigate the structure and conformation of various forms of myosin , and references therein). The latrunculins, 2-thiazolidinonecontaining macrolides from the Red Sea sponge Latrunculia magnifica, comprise another class of sponge metabolites useful as biochemical probes. Latrunculin A (Figure 3k) is an order of magnitude more potent than cytochlasin at disrupting microfilaments in cultured cells and affects different components of the actin-based cytoskeleton. The latrunculins are the only alternative to the cytochlasins in pharmacological studies of both actin polymerization in vitro and actin organization in living cells , and references therein).
Another important class of enzyme inhibitors from sponges are phospholipase A2 (PLA 2 ) inhibitors.
PLA 2 is responsible for releasing arachidonic acid, a key molecule involved in the biochemical processes that lead to many inflammatory conditions. Sponge inhibitors of PLA 2 , such as manoalide ( Figure  31 ) and scala radial (Figure 3m ), have provided researchers with important tools to study the role of this enzyme in inflammation (Potts et al. 1992 ).
The Caribbean sponge Discodermia dissoluta produces a novel polyhydroxylated lactone, discodermolide (figure 3n), with potent immunosuppressive activity. In vitro assays showed that the immunosuppressive activity of discodermolide is approximately equivalent to that of cyclosporin A. Discodermolide is 100-1000 times more potent than cyclosporin A in vivo and is equal or superior to FK506, two clinically useful immunosuppressive agents 278 (Loogley or aJ. 1991).
A variety of marine metabolites with activity as receptor antagonists and potential as either biochemical tools or structural leads for the design of therapeutics have recently been reported. Xestobergsterol A, a novel steroid from the Okinawan sponge Xestospongia bergquista, is a receptor antagonist that strongly inhibits immunoglobin E-mediated histamine release from mast cells. This sterol is more than 5000 times more potent than the well-known antiallergic drug disodium cromoglycare (Shoji er aJ. 1992) .
Sponges have been the source of several additional receptor antagonists. One of these is leucettamine A (Figure 30 ), a novel imidazole alkaloid from Palaun collections of the sponge Leucetta microraphis. Leucettamine A is a potent and selective antagonist for the receptor for leukotriene B4 (LTB,,), a non peptide metabolite of arachidonic acid produced mainly in inflammatory cells. Leukotrienes are important mediators of inflammation, with LTB4 being a proinflamma tory media tor in several common diseases; leucetamine A is therefore a new structural lead for the treatment of inflammatory diseases (Chan et al. 1993 ). The sesquiterpene lactone 15acetylthioxyfurodysinin lactone (Figure 3p ), from the Palaun sponge Dysidea sp., binds to LTB4 receptors with high affinity (Carte et al. 1989 ). Its ability to act as an agonist in the low nanomolar concentration range and activate the receptor-mediated signal transduction process related to LTB4 makes it a useful molecular tool for studying the role of leukotrienes in inflammation (Mong er aJ. 1990 ).
HIV-l, the causative agent of AIDS, cannot replicate autonomously but first must infect host cells. A potential molecular target for AIDS therapeutics is the binding site for the HIV-l virus on host T cells. Binding occurs by an interaction between the HIV-l surface glycoprotein gp 120 and CD 4 receptors on T cells. Using an enzyme-linked immunosorbent assay (ELISA) employing recombinant soluble CD 4 and recombinant HIV-l gp120, researchers at SmithKline Beecham isolated a series of novel polycyclic guanidine alkaloids from the Caribbean spongeBatzella sp. Batzelladine A (Figure 3q) and B (Figure 3r ) exhibited potent inhibition of CD / gp120 binding in both ELISA and cell-based assays and are therefore potential1eads forHIV therapy (Pati! er aJ. 1995).
Cnidaria
The phylum Cnidaria comprises a large group of diverse marine animals including jellyfish, sea anemones, hydro ids, and corals. Most cnidarians are considered carnivorous; however, several of them contain large numbers of intracellular symbiotic algae, the zooxanthellae, which are the vegetative state of dinoflagellates. Important metabolic exchanges occur between these symbiotic partners, and the photosynthetic activity of these zooxanthellae is of paramount importance to the energy balance of a coral reef. Natural product studies of the subphylum Medusozoa (e.g., jellyfish and hydroids) that use stinging cells to deter predators and of the physically protected hard reef-building herma typic corals ha ve been relativey unproductive. Tbe majority of interesting metabolites have been isolated from soft corals (order Alcyonacea) and gorgonians (order Gorgonacea), with fewer examples from zooanthid sea anemones (order Zoantharia) and sea pens (order Pennatulacea).
Both soft corals and gorgonians are abundant in tropical reef habitats, the Indo-Pacific being dominated by soft corals and the western Atlantic reefs by gorgonians. Both are prolific producers of terpenoids, especially diterpenes (Faulkner 1995) . The discovery in the late 1960s and early 19705 that some gorgonians contain large quantities of prostaglandins was responsible in part for the ra pid growth of the field of marine natural products. This finding stimulated a worldwide survey of prostaglandins in coelenterates, with an eye toward the commercial harvesting of these important metabolites from marine coelenterates. Efficient synthetic routes to the prostanoids were developed before extensive harvesting of wild corals occurred.
Hawaiian legends told of a specific tidepool that had a so-called toxic moss that was smeared on spear points to make them fatal. The toxic moss turned out to be not a seaweed but an animal of the phylum Cnidaria, family Zoanthidae. The structure elucidation of one of the most potent nonprotein toxins known, palytoxin (Figure 4a ), isolated from this toxic organism, Palythoa sp., was a highlight of the field of natural products chemistry. More recently, palytoxin analogs have been isolated from the dinoflagellate Ostreopsis siamensis, calling into question the biogenetic origin of palytoxin (Usami et al. 1995) . Palytoxin stimulates arachidonic acid metabolism and down regulates the response to epidermal growth factor by activating a sodium pump in a signal transduction pathway using sodium as a secondary messenger. These activities make palytoxin a useful tool for probing cellular recognition processes , and references therein).
Lophotoxin (Figure 4b) , a diterpene lactone isolated from gorgonian corals of the genus Lophogorgia, is a paralytic toxin that produces an irreversible postsynaptic blockade at neuromuscular junctions by inactivating acetylcholine nicotinic receptors. Lophotoxin binds preferentially to a nicotinic subunit of these receptors. Because of its ability to selectively block out a cholinergic nicotinic pathway in a complex set of interacting neurons, lophotoxin is an important neuropharmacological probe in studying complex pathways in neurobiology (Jacobs er al. 1985) .
Gorgonians of the genus Pseudopterogorgia are among the most chemically prolific of the corals in the tropical Atlantic Ocean. The pseudopterosins are important, chemically novel tricyclic diterpene pentosides isolated from Pseodopterogorgia elizahethae. The pseudopte rosins show anti-inflammatory and analgesic activities equal in potency to the industrial standard indomethacin. Importantly, one of the metabolites, pseudopterosin E (Figure 4c) , is nontoxic in acute toxicity assays at levels in excess of 300 mg/ kg. In mechanistic studies, pseudopterosin E inhibited the synthesis of leukotrienes, suggesting that it is an antagonist of Jipoxygenases or enzymes higher in the arachidonic acid response cascade. The anti-inflammatory and analgesic properties of the pseudopterosins suggest they represent new leads in the development of pharmaceuticals for the treatment of disease involving abnormal phospholipid metabolism (Roussis et al. 1990 ). Another class of bicyclic diterpene glycosides, exemplified by fuscoside A (figure 4d ) from the Caribbean gorgonian Eunicea fusca, have similar mechanistic and pharmacological properties and may also playa role in the design of new classes of selective nonsteroidal anti-inflammatory agents (Shin and FenicaI1991).
Bryozoans
Bryozoans (phylum Ectoprocta), or moss animals, are small colonial filter-feeding animals, called zooids, that resemble small colonial hydroids (phylum Cnidaria). Zooids have polyplike tentacles encircling the mouth, but unlike polyps, they have a complete digestive system. They form a colonial skelewn that partitions and separates one zooid from the next. The skeletal chambers may be oval, tubular, vaselike, or rectangular and are usually less than 2 mm across. The colonies of different species vary greatly in appearance. Some resemble a clump of seaweed or moss, others grow as lacy fans, and still others simply form encrustations on a variety of substrates. Because of their small size and the consequent difficulty in collecting sufficient material for analysis, chemical studies of hryozoans have been limited. However, several metabolites have been identified, most of them novel alkaloids (Faulkner 1995) .
Florida collections of the bryozoan Amathia convoiuta have yielded a series of novel y-Iactams, the convolutamides (Zhang et al. 1994 ). The convolutamides belong to a novel class of natural products possessing a structurally unique ylactam and dihromophenol ring system. One of the major metabolites, convolutamide A (Figure 5a ), exhibits in vitro cytotoxicity against L1210 murine leukemia cells and KB human epidermoid carcinoma cells. Crude extracts of the New Zealand bryozoan Cribricellina cribraria exhibit potent cytotoxicity. Bioassay-guided fractionation of the crude extract yielded a series of B-carboline alkaloids {Primep et al. 1991} . The major metabolite, \vinyl-8-hydroxy-B-carboline ( Figure  5b) exhibited cytotoxic, antibacterial, antifungal, and antiviral activities. Cytotoxic isoquinolinequinones with a relatively uncommon thiomethyl ether functionality, such as perfragilin A (Figure 5c ), wete isolated from the bryozoan Membranipora perfragilis. The structures of the perfragilins are reminiscent of the isoquinoline antibiotics produced by the actinomycete Streptomyces iauendu/ae, and Choi et al. (1993) speculated that these metabolites might actually be produced by a microbial symbiont of the bryozoan. The temperate water bryozoan Flustra foliacea has yielded more than 15 novel indole alkaloids, including flustramine E (Figure Sd) . Samples collected in Canadian waters provided alkaloids with strong antimicrobial activity, whereas the closely related alkaloids from North Atlantic samples lacked significant activity (Holst et al. 1994) . Sessibugula translucens was determined to be the source of a family of antimicrobial and cytotoxic bipyrrole alkaloids, the tambjamines, that were originally isolated from nudibranch molluscs. The tambjamines appear to play an intimate role in the chemical ecology of the bryozoan S. translucens and its nudibranch predators (Carte and faulkner 1986). Although the above and other interesting bryozoan alkaloids have been reported to have in vitro antimicrobial or cytotoxic activity, there are few reports of more relevant in vivo activity for these compounds.
The most important and unusual class of bryozoan metabolites are the bryostatins, from Bugula neritina (for review, see Pettit 1991) . Figure 5 . Metabolites from marine bryozoans. B . nerilina is a purplish-brown bryozoan that is abundant in temperate ocean locations and is a serious shipfouling species. This bryozoan forms tuftlike colonies of up to 8 em in height, but the usual size is approximately 2 cm. In the late 19605, extracts of B. nerilina were found to be exceptionally promising because they were capable of extending the lives of mice bearing PS leukemia by more than 100%. Since this original discovery, a total of 15 cytotoxic bryostatins have been isolated and identified. The bryostatins are a family of macrocyclic Jactones with the same unprecedented 26-membered "bryopyran" skeleton. The members of this family differ principally in the ester groups linked to the macrocyclic lactone ring. Several bryostatins, including the most widely studied and major metabolite, bryostatin 1 ( Figure Se) , exhibit exceptionally potent anticancer activity in vivo, with remarkable selectivity against human leukemia, renal cancer, melanoma, and non-small cell lung cancer cell lines. The mechanism of action of bryostatin 1 involves modulation of the signal transduction enzyme PKC. At low concentrations (10 nanomolar range) bryostatin 1 stimulates the activity of PKC in a similar manner as the tumor-promoting phorbol esters. However, bryostatin 1 has no tumor-promoting activity and is in fact likely to block the tumor-promoting effects of the phorbol esters. Clinical development of the hryostatins has been hampered by insufficient supplies, but a largescale collection of 11,000 gallons of B. nerilina begun in 1988 provided sufficienr material for early clinical trials. Collaborative research efforts arc also underway to culture B. neritina and to determine whether the bryostatins may be synthesized by a microbial symbiont that might be culturabJe.
Initial phase I human clinical trials of bryostatin 1 have recently been published (Philip et al. 1993 , PrendiviHe et al. 1993 ). The major side effects of bryostatin were doserelated myalgia and a transient and immediate fall in platelet counts, which returned to normal in seven days. The phase r clinical trials established recommended dosing schcdules for further clinical trials and demonstrated that bryostatin 1 can be safely given with minimal side cffects and can induce a tumor response. Regardless of the eventual outcome of the anticancer clinical trials of bryostatin 1, this compound continues to be a potent probe for studying the complex roles of PKC signal transduction in cellular processes.
Molluscs
The Latin name Mollusca means soft body, which describes these animals because they lack a true skeleton. A majority of the phylum members have a protective external shelt made of calcium carbonate secreted from a specialized layer of the animals' outer tissue called the mantle. The phylum can he divided into five major classes, all of which are represented in the marine environment. The natural products chemistry of three of the molluscan classes, Amphineura (chitons), Scapbopoda (tusk shells), and Cephalopoda (squids and octopi), have not been explored to any degree. Because of the commercial value of the class Pelecypoda or Bivalvia (clams, oysters, mussels, scallops), the chemistry of this class has been studied. However, most chemical work on this group has looked at potentially harmful pollutants concentrated by these filter-feeding organisms. These have been both anthropogenic and natural chemicals, such as the paralytic and diarrhetic shellfish toxins produced by marine microalgae. The majority of natural product studies of the Mollusca have been in the class Gastropoda.
The class Gastropoda (stomach foot) is divided into three subclasses, the Prosobranchia (gills forward), the Opisthobranchia (gills behind), and the Pulmonata (lunged). The subclass Prosobranchia are the familiar shelled snails, the largest class of molluscs. Because of the physical protection provided by the shell the prosobranchs tend not to contain interesting secondary metabolites. One exception is the predatory cone shells of the genus Cunus. This genus includes species that specialize in killing and eating fish and other organisms that prey on molluscs or worms. To be effective hunters, these snails have evolved deadly mixtures of nerve toxins, small, conformationally constrained peptides of 10 to 30 amino acids, that paralyze prey. These venoms, or conotoxins, are targeted to various ion channels and receptors. Some block channels regulating the flow of potassium or sodium across the membranes of nerve or muscle cells. One type binds to N-mcthyl-D-aspartate receptors, wbich are triggered by glutamate to allow calcium ions to flow into nerve cells. Some arc specific antagonists of acetylcholine receptors respon- sible for muscle contraction. The conoroxins have provided neuroscientists and molecular pharmacologists with a rich source of new and exquisitely precise chemical probes for dissecting and manipulating ion channels and receptors, and they are used in hundreds of research laboratories for a variety of physiological and pharmacological investigations (Myers et al. 1993 ).
Another important biochemical probe compound from the subclass Prosobranchia is the heterocyclic glycoside neosurugatoxin (Figure 6a ) isolated from the Japanese ivory mollusc Babylonia japonica. Neosuruga toxin is a reversible antagonist of acetylcholine receptors that was useful in characterizing two subclasses, high and low affinity, of this receptor (Ireland et 011. 1993, and references therein) .
Marine examples of the Gastropod subclass Pulmonata are airbreathing molluscs that normally inhabit the high intertidal zone. Limited chemical work has focused on the family Siphonariidae (false limpets), which produces polypropion ate-derived natural products such as the antibiotic diemenensin-A (figure 6b) from Australian collections of Siphonaria diemenensis (Hochlowski and Faulkner 1983) .
By far, the majority of natural product research in the Mollusca has been on the subclass Opisthobranchia, the shell-less snails. Most members of this subclass lack an external shell. The mantle covers the animal's back and is often colorful, with flamboyant designs. Interest in the chemistry of opistobranch molluscs has been based on the finding that manv concentrate metabolites from th·eir highly specialized diets and incorporate them into their own defensive strategies (Faulkner 1988) . Many biological studies of the natural products from these molluscs have thcrefore concentratcd on potential ecological roles of the compounds.
The sea hares (order Anaspidea) are herbivorous opisthobranch molluscs that concentrate and store selected algal metabolites. The sea hare Dolabella auricularia, collected in the Indian Ocean, has been the source of more than 15 cytotoxic peptides, the dolastatins. The dolastatins are a collection of cyclic and linear peptidcs and de psipeptides that display remarkable in vitro cytotoxicity and impressive in vivo antitumor activity at low doses (Schmitz et al. 1993 , and refcrences therein). The most active metabolite, dolastatin 10 (Figure 6c ), is one of the most potent antineoplastic substances known. The development of synthetic methods to produce dolastatin lOis likely to allow a broad assessment of its biological properties and accelerate its preclinical development (Pettit et al. 1989 ),
The Opisthobranch order Nudibranchia (naked gills) are snails in which all vestiges of a shell are lost in the adult stage. The gills are typically located on the dorsal surface toward the posterior end of a sluglike body, looking like a bundle of plumes. Nudibranchs are a favorite subject of underwater photographers because they are among the most visually exciting invertebrate animals. Most nudibranchs are carnivorous, concentrating secondary metabolites from their selective diet of sponges, bryozoans, ascidians, and coelenterates. It has been argued that 282 the nudibranchs owe their evolutionary success to the development of a chemical defense system obtained from their invertebrate diets (Faulkner and Ghiselin 1983) . Among the most interesting metabolites isolated from nudibranchs are novel sponge-derived trisoxazolecontaining macrolides, which are used by the nudibranchs to chemically defend their highly colored and vulnerable egg masses. One such example, ulapualide A (Figure 6d) , isolated from the egg masses of the brilliant red Spanish dancer nudibranch Hexabranchus sanguineus, exhibits potent cytotoxic activity against L1210 murine leukemia cells and antifungal activity that exceeds that of the clinically useful amphotericin B (Roesener and Scheuer 1986) . Like amphotericin B, however, these trisoxazole metabolites are toxic and have a similarly poor therapeutic index. Tropical nudibranchs of the genus Chromodoris use a family of rearranged spongian diterpenes, acquired from dietary sponges, as a chemical defense. Chromodorolide A, isolated from Indian Ocean collections of Chromodoris cavae, exhibits in vitro antimicrobial and cytotoxic activity as well as moderate in vivo antitumor activity against P388 murine leukemia cells (Morris et al. 1990) .
Onchidella binneyi is an opisthobranch mollusc that inhabits rocky intertidal zones in the Sea of Cortez. Like other opisthobranchs, the Onchidacea do not have the physical protection provided by a shell but rely on the production of a defensive secretion. The defensive secretion of O. binneyi contains a single lipid-soluble compound, onchidal (Figure 6e ), which is an irreversible substrate inhibitor of acetylcholinesterase with a novel mechanism of action. This activity makes onchidal useful for identifying the active site residues that contribute to binding and hydrolysis of acetylcholinesterase ),
Ascidians
Ascidians belong to the phylum Chordata, which encompasses all vertebrate animals. Ascidians are commonly called tunicates, because their body is covered by a sac1ike case or tunic. They are also known as sea squirts, because many expel streams of water through a siphon when disturbed. Although adult ascidians are exclusively marine invertebrates and bear little resemblance to other chordates, their larvae resemble amphibian tadpoles and contain notochords, which are lost during development. Adult ascidians are sessile filter feeders, either solitary or colonial, and live preferentially in regions that receive considerable freely flowing water yet are protected from wave shock. Solitary tunicates can be up to 15 cm in length. Colonial species often encrust a hard substrate such as rocks and may be extremely thin and delicate or as thick as 5 cm. The natural products chemistry of ascidians has been driven by tbe frequent discovery of biologically active metabo-lites, most of which are amino acid derivatives (Davidson 1993) .
The Caribbean tunicate, Trididemnum solidum, is a gray-green, flat, pancake like tunicate that encrusts rocks or corals to a depth of 40 m. In shipboard testing, T. solidum extracts exhibited both antiviral and cytotoxic activities. Continuing research has yielded a family of novel cyclic depsipeptides, the didemnins, which exhibit an impressive array of in vivo antitumor, antiviral, and immunosuppressant activities (Rinehart et al. 1993 ). Large-scale collections of this thinly encrusting tunicate provided sufficient amounts of one of the most potent metabolites, didemnin-B (Figure 7a) , that it could pass through preclinical studies and become the first marine compound to enter human cancer clinical trials as a purified natural product. Preclinical and phase I studies defined a maximal tolerated dosing schedule and determined that the dose-limiting toxicities were reversible gastrointestinal and liver toxicity. Unfortunately, in recently completed phase II clinical studies to determine efficacy in kidney, ovarian, and breast cancers, didemnin-B demonstrated significant toxicity and failed to show any significant anticancer activity (Davidson 1993 , and references therein). Nevertheless, the didemnin class of cyclic peptides remains an important structural lead for a variety of antiviral, anticancer and immunosuppressant activities, and research continues on the isolation and synthesis of new didemnin analogs (Sakai ot al. 1995) .
Ecteinascidia turbinata is a translucent orange colonial tunicate that commonly grows in clusters in Caribbean mangrove habitats. It has been known for more than 25 years that crude extracts of E. turbinata exhibit in vivo antitumor activity, but it was not until recently that a series of tetrahydroisoquinoline alka[oids, the ecteinascidins, were isolated and shown to be responsible for the antitumor activity of the crude extracts (Rinehart et al. 1990 , Wright et al. 1990 ). Ecteinascidin 729 (Figure 7h) is currently undergoing preclinical evaluation at NCI on the basis of its exceedingly potent activity in vivo against a variety April 1996 of mouse tumor models (Sakai et al. 1992) . Human anticancer clinical trials with ecteinascidins are expected to begin by 1996.
Tunicates of the genus Eudistoma have been exceptionally prolific producers of biologically active metabolites. Shipboard testing of Caribbean extracts of Eudistoma olivaceum indicated they contain extremely potent antiviral activity against Herpes simplex viruses. So far, more than 20 tryptophan-derived B-carboline a[kaloids, the eudistomins, ha ve been isolated from this tunicate. The eudistomins can be divided into four groups based on the nature of the Bcarboline structure (i.e., unsubstituted, pyrrolyl-su bstitu ted, pyrrolinyl-su bstituted, and tetrahydro-carbolines containing an oxathiazepine ring). The latter class, exemplified by eudistomin C (Figure 7c ), exhibit potent in vitro antiviral activity. The most promising eudistomins have now been produced synthetically in sufficient amounts for in vivo antiviral analysis (Rinehart et a I. 1993) .
Two further collections of Eudistoma sp. gave derivatives of the potent PKC inhibitor staurosporine, an alkaloid produced by Streptomyces sp. As mentioned previously, specific inhibitors of PKC can be powerful tools to study the role of this enzyme in cellular proliferation and differentiation and may lead to therapeutic agents for cancer and inflammation. A sample of Eudistoma sp. collected off of West Africa yielded staurosporine aglycone (Figure 7d ; Horton et a!. 1994), whereas a Western Pacific collection produced 11-hydroxystaurosporine ( Figure 7ei Kinnel and Scheuer 1992). The latter is a more potent PKC inhibitor than staurosporine. A collection of Eudistoma sp. from Micronesia recently yielded a new class of potent and selective PKC inhibitors, trithianes and pentathiepins, a class of compounds also found in tunicates obhe genus Lissoclinum (Carte et al. 1994) .
The tunicate genus Lissoclinum has been a productive source of additional biologically active compounds. In addition to the trithianes and pentathiepins, a new class of cytotoxic macrolides, exemplified by bistratene A (Figure 7f ), was isolated from a New Caledonian col-lection of Lissoclinum bistratum. Whereas the pentathiepins and staurosporine analogs are potent PKC inhibitors, the bistratenes enhance the phospholipid-dependent activity of PKC and therefore may be useful probes for studying molecular mechanisms of cell growth and differentiation (Foster et al. 1992) . The genus Lissoclinum is best known as a prolific producer of cyclic peptides, many of which show interesting cytotoxic or antiviral activities. Two major classes of cyclic peptides, the he pta peptide lissoclinamides and the octapeptide pate 11 a mi de sl u I i thi a cycl am ides, have been isolated from L. patella. Each is characterized by the presence of thiazole and oxazoline amino acids (Davidson 1993) . Ulithiacyclamide (Figure 7g ), one of the most potent of the Lissoclinum peptides, shows potent in vitro and in vivo anticancer activity (Ireland et al. 1988 ).
Miscellaneous manne organisms
Natural product chemists have also examined the phylum Echinodermata for biologically active metabo[ites. The echinoderms are a strictly marine group that have a wide distribution and are common from intertidal areas to great depths. The phylum is divided into five major classes, Asteroidea (sea stars or starfish), Crinoidea (crinoids or stalked feather stars), Echinoidea (sea urchins, sand dollars, and sea biscuits), Holothuroidea (sea cucumbers), and Ophiuroidea (brittlestars and basket stars). Studies of the natural products chemistry of echinoderms have focused almost exclusively on the physiologically active saponins from sea stars (Asteroidea) and sea cucumbers (Holothuroidea). The sea star saponins, such as the cytotoxic pectinioside E from Asterias pectinifera (Dubois et al. 1988 ), tend to be glycosides of steroids, whereas saponins from sea cucumbers, such as the cytotoxic and antifungal cucumechinoside F from Cucumaria echinata (Miyamoto et al. 1989) , are based on triterpenoids rather than steroids. Although several biologically active saponins have been reported from echinoderms, the tendency of saponins to cause cell lysis has prevented them from being used either as drug leads or as biochemical tool compounds. One of a few nonsaponin metabolites from echinoderms is imbricatine (Figure 8a) , the first benzylterrahydroisoquinoline alkaloid from a nonplant source, isolated from the temperate water sea star Dermasterias imbricata (Burgoyne et al. 1990 ). Imbricatine elicits an unusual swimming escape response in anemones that D. imbricata preys on and displays potent in vitro cytotoxicity and moderate in vivo antitumor activity. Occasional reports of natural products from marine worms, fish, and crustaceans also appear in the literature (Faulkner 1995, and pre- vious reviews in this series). The most important metabolites from marine worms are the cephalostatins isolated from the South African tube worm Cephalodiscus gilchristi (Order Cephalodiscida; Pettit et al. 1994 ). The cephalostatins are unusual pyrazine alkaloids derived from two different steroidal subunits that have remarkable in vitro cytotoxicity. The most active of the metabolites is cephalostatin 1 (Figure 8b) , which exhibits in vitro cytotoxicity in the PS cell line with an ED 50 of 10-7 to 10· Y )lg/mL. The cephalostatins also demonstrate one of the most extreme examples of differential cytotoxicity yet encountered in the Ncr human cell line 284 screen, with an up to to,OOO-fold differential in sensitivity among different cell lines. These activities, together with the structure-activity relationships deduced for this family of steroidal alkaloids, make them an important prototype for detailed in vivo pharmacological evaluation against selected sensitive human tumor lines.
During a search for antibiotic substances from the gastrointestinal tract of various animal species, a new class of water-soluble, broadspectrum antibiotics was identified in stomach extracts of the dogfish shark Squalus acanthias (Moore et al. 1993 ). Squalamine (Figure 8c) is an unusual adduct of spermidine with an anionic bile salt intermediate that is without precedent in vertebrates. Squaiamine exhibits broad-spectrum antibiotic activity, including potent micro biocidal activity against Gram-negative and Gram-positive bacteria, fungi, and protozoa, and thus represents a lead for the design of a potentially new class of antibiotics.
Conclusions
The marine environment is a rich source of biologically active natural products of diverse structural types, many of which have not been found in terrestrial sources. Research on marine natural products has evolved from the purely chemical exercise of isolating novel structures to a col-laborative effort between marine chemists, molecular pharmacologists, and cell biologists. Sophisticated mechanism-based screens using specific enzymes, receptors, and recombinant whole cells are increasingly being used for identifying marine natural products with potential biomedical uses. For example, nucleosides from sponges provided the lead required for the design and development of ara-C, an agent used successfully for many years for the clinical treatment of leukemia and non-Hodgkin's lymphoma. More recently, several marine natural products have entered human clinical trials or are in preclinical development. Other marine natural products have provided chemical templates for the possible development of new classes of human therapeutics or have proven to be important tools or probes for the molecular study of complex biochemical and cellular processes. Although many of these products are not likely to become therapeutics, the information gained from studying them is likely to lead to the development and understanding of novel molecular targets, which in turn may lead to the development of new classes of therapeutic agents. With the rapid explosion of new molecular targets available for drug discovery and advances in automated highthroughput screening technologies, there has been a dramatic increase in interest by the pharmaceutical and biotechnology industries in sources of small-molecule molecular diversity. The resources of the marine environment are undoubtedly likely to play an important role in the discovery of novel lead structures for many of these new targets. New chemical technologies such as combinatorial chemical techniques are likely to provide the means to efficiently develop these structures into useful human therapeutics.
